Abstract: Genetically-modified plants having increased tolerance to heat stress are described. Methods of producing such genetically-modified plants are also disclosed. The genetically-modified plants comprise exogenous nucleic acid encoding a thermostable protein having starch synthase activity. Genetically-modified plants have increased yield when grown under elevated conditions as compared to control plants.

Abstract: A mixture comprising liquid water, a gas and at least one organic compound are injected into a non-thermal gas-liquid plasma discharge reactor to generate a flowing liquid film region with a gas stream flowing alongside. A plasma discharge is propagated along the flowing liquid film region. Water is dissociated and reactive species such as hydroxyl radicals, hydrogen peroxide and nitrogen oxides are formed. The organic compound reacts with the reactive species such as hydroxyl radicals and hydrogen peroxide present in the flowing liquid film region and in the flowing gas stream to produce organic compound dissociation products. At least some organic compound dissociation products and nitrogen oxides are transferred to a bioreactor for further degradation of organic compounds. The nitrogen oxides are used as nutrients for bacteria in the bioreactor. Feedback control of the plasma reactor is based on conditions detected and determined in the biological reactor.

Abstract: Porcine pestivirus designated herein as atypical porcine pestivirus (“APPV”) (Genbank accession no. KR011347.1). Immunogenic compositions to induce an immune response against porcine pestivirus infection in a pig are described, which APPV antigenic agents (e.g., isolated whole virus, derivatives thereof, functional fragments thereof, and combinations of the foregoing). Methods of vaccinating against porcine pestivirus infection using the immunogenic compositions are also described. The methods can be also applied for clinical research and/or study, including diagnostic methods for detecting pestivirus infection using monoclonal antibodies specifically binding to APPV epitopes.

Abstract: The present invention concerns the use of emetine compounds for the treatment or prevention of Flavivirus infections, such as Zika virus infections. Aspects of the invention include methods for treating or preventing Flavivirus virus infection, such as Zika virus infection, by administering an emetine compound such as emetine or cephaeline, or a combination of two or more emetine compounds, to a subject in need thereof; methods for inhibiting Flavivirus infections such as Zika virus infections in a cell in vitro or in vivo; pharmaceutical compositions; packaged dosage formulations; and kits for treating or preventing Flavivirus infections, such Zika virus infections.

Abstract: A system for and methods of analyzing a test sample through the use of a rotary apparatus that includes a microfluidic paper-based apparatus (mPAD). The apparatus includes two or more layers that are rotatable with respect to one another. A middle layer may comprise a microfluidic apparatus having one or more reagent channels. Each of the reagent channels may include reagent dried on the surface of the channel, and, together with an adsorption pad, may be aligned vertically with a sample chamber. Male and female engagement surfaces on each of the middle layer, the top layer, and the bottom layer interlock to secure each layers in vertical alignment so that fluid flows through the apparatus to contact a test sample with a reagent and facilitate detection of a target analyte in the test sample in the sample chamber.

Abstract: The present disclosure provides FGF1 mutant proteins having one or more mutations in the heparin binding domain. Such mutants may also have an N-terminal deletion, point mutation(s), or combinations thereof. In some examples, the mutant FGF1 proteins have reduced mitogenic activity. Also provided are nucleic acid molecules that encode such proteins, and vectors and cells that include such nucleic acids. The disclosed FGF1 mutants can reduce blood glucose in a mammal, and in some examples are used to treat a metabolic disorder.

Abstract: The present invention relates to technology for generating an ultrasound vector Doppler image using plane wave synthesis, and in a method for generating ultrasound Doppler images, a preset number of plane waves having different incident angles are sequentially and repeatedly transmitted to a target according to a transmission sequence, reflection signals are received from the target at different locations, an ensemble frame is generated by synthesizing, among the received reflection signals, a preset number of reflection signals for each of a positive angle and a negative angle with respect to a reference direction facing the target, and a vector Doppler image generated using a plurality of ensemble frames is output.

Abstract: The present invention is directed to polyisocyanates and polyurethanes derived therefrom. In various embodiments, the present invention provides polyisocyanates, methods of making the polyisocyanates from fused bicyclic alcohols, polyurethanes, and methods of making the polyurethanes from the polyisocyanates.

Abstract: A composite material comprising graphene or reduced graphene oxide and a polymer-derived ceramic material, such as SiOC, is provided. The composite materials can be used to construct anodes (16), which can be used in batteries (10), particularly lithium ion batteries. The anodes exhibit relatively high charge capacities at various current densities. Moreover, the charge capacity of the anodes appears exceptionally stable even after numerous charging cycles, even at high current densities.

Abstract: The present invention aims to dramatically increase the effect of hepatic arterial chemoembolization by developing human serum albumin-based nanoparticles, which are bioproteins that effectively carry Adriamycin in place of Adriamycin, an anticancer agent used in hepatic arterial chemoembolization. The human serum albumin nanoparticles carrying the Adriamycin not only intensively infiltrate the drug effectively into the cells but also have a synergistic effect that can induce a long-term therapeutic effect by utilizing the effect of continuous drug release from the particles.

Abstract: Provided are a non-volatile memory device and a method of fabricating the same. The non-volatile memory includes a channel layer, a data storage layer disposed on the channel layer, a plurality of control gates arranged on the data storage layer and spaced apart from one another, and conductive cover layers disposed on sidewalls of the control gates facing each other. The plurality of control gates includes a first conductor having a first work function. The conductive cover layers include a second conductor having a second work function that is greater than the first work function.

Abstract: Rhein analogues that exhibit anti-proliferative activity, particular against cancer cells, are described herein. In some embodiments, the compounds contain a flat or planar ring system. Such rings system by facilitate non-covalent binding of the compounds to the DNA complex, such as by intercalation. In some embodiment, the compounds contain a flat or planar ring system as described above and one or more substituents which are alkylating moieties, electrophilic groups or Michael acceptors or groups which contain one or more alkylating moieties, electrophilic groups and/or Michael acceptors. The compounds described herein can also contain one more functional groups to improve the solubility of the compounds.

Abstract: Printed poly(ethylene oxide) (PEO) organometallic halide Perovskite (Pero) optoelectronic devices, including light emitting diodes (LEDs) fabricated on both rigid indium tin oxide (ITO)/glass and flexible carbon nanotube (CNTs)/polymer substrates using a composite thin film of PEO and Br-Pero as the light-emitting layer. Method of manufacturing Printed poly(ethylene oxide) (PEO) organometallic halide Perovskite (Pero) optoelectronic devices performed in an environment at a temperature of about 25° C. and a relative humidity between about 70% and 80%.

Abstract: The present disclosure relates to wheat plants having grain with high ?-glucan content, methods for constructing said wheat plants, grain therefrom and uses thereof. Wheat lines homozygous for the HvCslF6 gene from barley having five times the fiber content and an increased ?-glucan content of TA5790, TA5792, and TA5795 are disclosed.

Abstract: Analogs of largazole are described herein. Methods of treating cancer, blood disorders, autoimmune disease, and Alzheimer's Disease using largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

Abstract: Simple ?-hairpin peptides in linear and cyclic form that specifically bind to HIV-1 Trans-Activation Response element (HIV-1 TAR), as well as compositions and use thereof are described.

Abstract: A fluid-filled hollow optical fiber cell broadly includes a hollow-core optical fiber and a fluid. The optical fiber presents first and second fiber ends and a longitudinal passageway that extends continuously between the fiber ends. The fluid occupies the passageway, with the fiber ends being closed to hermetically seal the fluid within the optical fiber. The first fiber end has a rounded closed shape formed by at least partly melting the first fiber end to form melted fiber material, with the fiber material being permitted to solidify without splicing the first fiber end to another fiber so that the fiber material terminates the passageway at the first fiber end.

Abstract: A color fringe is corrected by detecting a transition region that includes pixels adjacent in a linear direction. A color difference distribution in the transition region is modeled by a logistic function. Pixel color values in the transition region are corrected using the logistic function to maximize a correlation between a correction color and a reference color with respect to the transition region. Color distortion such as color fringes is corrected without corrupting the original colors of the image by modeling the color difference by the logistic function while maximizing the correlation using information of the undistorted region. A calculation cost is reduced by reducing the number of the parameters required to optimize the logistic function.

Abstract: Provided herein is a soft tissue mimetic formed from a block copolymer hydrogel and methods of making such. The hydrogel comprises a glass formed from a dry blend of polystyrene-poly(ethylene oxide) diblock copolymer (SO) and polystyrene-poly(ethylene oxide)-polystyrene triblock copolymer (SOS) in a molar ratio from between 95:5 and 1:99 SO/SOS and a liquid medium at a concentration between about 32:1 and about 2:1 liquid medium/SO-SOS by weight. The soft tissue mimetic has a fatigue resistance to at least 500,000 compression cycles.

Abstract: Disclosed are a system and method for controlling land deformation, and a method for optimal design of a well in a system for controlling a well in a system for controlling land deformation. The land deformation control system with respect to a land including an confined aquifer and an aquiclude above the confined aquifer includes a first well for water pumping from or water injecting into the confined aquifer; and one or more second wells spaced apart from the first well by a predetermined distance and having a lower end portion positioned in the aquiclude, wherein a water level of the second well is maintained at a preset water level value to control an amount of change in water head of the aquiclude, which drops due to pumping of the confined aquifer or rises due to injection with respect to each of the second wells.